Zealand Pharma A/S
CSE:ZEAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zealand Pharma A/S
CSE:ZEAL
|
DK |
|
GEA Group AG
XETRA:G1A
|
DE |
|
Bukalapak.com Tbk PT
IDX:BUKA
|
ID |
|
Richards Group Inc
TSX:RIC
|
CA |
|
Bayan Resources Tbk PT
IDX:BYAN
|
ID |
|
General Electric Co
NYSE:GE
|
US |
|
N
|
NP3 Fastigheter AB
STO:NP3
|
SE |
|
A
|
Amerant Bancorp Inc
NYSE:AMTB
|
US |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
|
Toshiba Corp
TSE:6502
|
JP |
|
A
|
Autopedia Sukses Lestari Tbk PT
IDX:ASLC
|
ID |
|
Rheinmetall AG
XETRA:RHM
|
DE |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
K
|
Ke Holdings Inc
HKEX:2423
|
CN |
|
DICK'S Sporting Goods Inc
NYSE:DKS
|
US |
|
Korea Electric Power Corp
KRX:015760
|
KR |
|
Aramark
NYSE:ARMK
|
US |
|
C
|
China Environmental Resources Group Ltd
HKEX:1130
|
HK |
|
Federal National Mortgage Association
OTC:FNMA
|
US |
|
Truist Financial Corp
NYSE:TFC
|
US |
|
Virgin Galactic Holdings Inc
NYSE:SPCE
|
US |
|
C
|
CRH PLC
NYSE:CRH
|
IE |
|
Hershey Co
NYSE:HSY
|
US |
|
Cencosud SA
SGO:CENCOSUD
|
CL |
Bankruptcy Probability
Zealand Pharma A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zealand Pharma A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Zealand Pharma A/S
CSE:ZEAL
|
20.8B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zealand Pharma A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zealand Pharma A/S has total debt of 383.1m DKK. This includes both short-term (0 DKK) and long-term (383.1m DKK) debt.
You can find a full breakdown on its Balance Sheet.
